Related Experiment Video
Updated: Dec 17, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Hypermethylation of tumor necrosis factor decoy receptor gene in non-small cell lung cancer
Yuanlin Qi1, Lin Qi1, Minglian Qiu2
1School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian 350122, P.R. China.
Abstract:
Abnormal methylation of the TNFRSF10C and TNFRSF10D genes has been observed in numerous types of cancer; however, no studies have investigated the methylation of these genes in non-small cell lung cancer (NSCLC). The aim of the present study was to investigate the association between TNFRSF10C and TNFRSF10D methylation and NSCLC. Methylation levels of 44 pairs of NSCLC tumor tissues and distant non-tumor tissues were analyzed using quantitative methylation specific PCR and methylation reference percentage values (PMR). The methylation levels of the TNFRSF10C gene in NSCLC tumor tissue samples were significantly higher compared with those in the distant non-tumor tissues (median PMR, 2.73% vs. 0.75%; P=0.013). Subgroup analysis demonstrated that the methylation levels of TNFRSF10C in tumor tissues from male patients were significantly higher compared with those in distant non-tumor tissues (median PMR, 2.73% vs. 0.75%; P=0.041). The levels of TNFRSF10C methylation were also higher in the tumor tissues of patients who were non-smokers compared with their distant non-tumor tissues (median PMR, 2.50% vs. 0.63%; P=0.013). TNFRSF10C methylation levels were higher in the tumor tissues from male patients compared with those from female patients (median PMR, 2.50% vs. 0.63%; P=0.031). However, no significant differences in the methylation levels of the TNFRSF10D gene were observed between the sexes. Using the cBioPortal and The Cancer Genome Atlas lung cancer data, it was demonstrated that TNFRSF10C methylation levels were inversely correlated with TNFRSF10C mRNA expression levels (r=-0.379; P=0.008). In addition, demethylation of lung cancer cell lines A549 and NCI-H1299 using 5'-aza-deoxycytidine further confirmed that TNFRSF10C hypomethylation was associated with significant upregulation of TNFRSF10C mRNA expression levels [A549 fold-change (FC)=8; P=1.0×10-4; NCI-H1299 FC=3.163; P=1.143×10-5]. A dual luciferase reporter gene assay was also performed with the insert of TNFRSF10C promoter region, and the results revealed that the TNFRSF10C gene fragment significantly enhanced the transcriptional activity of the reporter gene compared with that in the control group (FC=1.570; P=0.032). Overall, the results of the present study demonstrated that hypermethylation of TNFRSF10C was associated with NSCLC.
Insights
Hypermethylation of the TNFRSF10C gene is associated with non-small cell lung cancer (NSCLC). This study found higher TNFRSF10C methylation in NSCLC tumors, particularly in male and non-smoking patients, and linked it to reduced gene expression.
Area of Science:
- Molecular Oncology
- Epigenetics
- Cancer Genomics
Background:
- Aberrant methylation of TNFRSF10C and TNFRSF10D genes is implicated in various cancers.
- Previous research has not explored the methylation status of these genes in non-small cell lung cancer (NSCLC).
- Understanding gene methylation patterns is crucial for identifying novel biomarkers and therapeutic targets in NSCLC.
Purpose of the Study:
- To investigate the association between TNFRSF10C and TNFRSF10D gene methylation and the occurrence of NSCLC.
- To explore potential correlations between methylation levels, patient demographics, and gene expression.
- To elucidate the functional impact of TNFRSF10C methylation on gene transcription.
Main Methods:
- Quantitative methylation-specific PCR (QMSP) was employed to analyze methylation levels in 44 pairs of NSCLC tumor and adjacent non-tumor tissues.
- Analysis of The Cancer Genome Atlas (TCGA) lung cancer data and cBioPortal was performed to correlate methylation with mRNA expression.
- In vitro experiments included demethylation of NSCLC cell lines (A549, NCI-H1299) and a dual luciferase reporter gene assay to assess transcriptional activity.
Main Results:
- Significantly higher TNFRSF10C methylation levels were observed in NSCLC tumor tissues compared to non-tumor tissues (P=0.013).
- Elevated TNFRSF10C methylation was noted in male patients (P=0.041) and non-smokers (P=0.013), and was higher in male versus female patients (P=0.031).
- TNFRSF10C methylation inversely correlated with its mRNA expression (r=-0.379; P=0.008), and demethylation led to significant gene upregulation.
Conclusions:
- Hypermethylation of the TNFRSF10C gene is significantly associated with non-small cell lung cancer.
- TNFRSF10C methylation may serve as a potential biomarker for NSCLC, with distinct patterns observed in specific patient subgroups.
- The findings suggest that TNFRSF10C methylation influences gene expression, potentially impacting NSCLC pathogenesis.
More Related Videos
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
06:07Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022